EQL Pharma AB — Investor Relations & Filings

EQL Pharma AB is a pharmaceutical company that develops, markets, and sells generic and specialty medicines. The company's strategy centers on identifying and developing "niche generics," which are medically equivalent to originator drugs but face limited competition after patent expiration. Its business operations also include specialty pharmaceuticals and the parallel import of medicines. EQL Pharma emphasizes cost-efficiency and collaborates with a global network of development partners. The company serves pharmacies and hospitals, primarily in the Nordic markets, maintaining a portfolio of marketed products while cultivating an extensive pipeline of new medicines.